PAULINE PARK-MAXWELL: Open Payments
NPI 1831833474 · HAMILTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 13 payments from 7 companies in 2025. Trend: 2023 $14 · 2024 $82 · 2025 $487
Food & beverage: $376Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $307 |
| E.R. Squibb & Sons, L.L.C. | 1 | $79 |
| ABBVIE INC. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Alkermes, Inc. | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: UZEDY, COBENFY, VRAYLAR, REXULTI, AUSTEDO XR, INVEGA SUSTENNA, ARISTADA, FANAPT.
Industry payments across NJ — which companies pay providers there.
